LACTEL 50:50 DL-PLG (B6010-3) is a biomedical-grade poly(DL-lactide-co-glycolide) copolymer supplied with a 50:50 molar ratio of DL-lactide to glycolide and a terminal carboxylic acid function. The polymer is amorphous at physiological and processing temperatures because the DL-lactide fraction prevents stereoregular crystallization. The B6010-3 designation places the material in the intermediate inherent-viscosity range of the acid-terminated 50:50 DL-PLG series; this viscosity window is intended for solvent-based particle formation, low-shear molding, and extrusion processes where lower melt viscosity and rapid hydration are advantageous. The material is used in absorbable implant prototyping, controlled-release matrix fabrication, and tissue engineering scaffolds. Because the copolymer is degradable by hydrolytic chain scission, the processing environment must exclude excessive moisture and high temperatures, and all final-device performance must be validated under the intended sterilization and packaging conditions.

Which release methods define the B6010-3 specification envelope?

Batch acceptance data are generated by dilute-solution viscometry, chromatographic monomer analysis, and elemental residue testing. Inherent viscosity is measured at 30 °C in chloroform at 0.1 g/dL with a capillary viscometer following ASTM D2857 or ISO 1628-1. The release window for B6010-3 is typically 0.25–0.35 dL/g; the vendor certificate of analysis is the governing document because occasional lot-specific variation may occur. Copolymer composition is confirmed by ¹H NMR spectroscopy; residual lactide and glycolide monomers are quantified by gas chromatography with flame-ionization detection; tin catalyst residues are determined by inductively coupled plasma mass spectrometry. The polymer is soluble in dichloromethane, chloroform, tetrahydrofuran, acetone, and ethyl acetate, while precipitation occurs in water, methanol, and hexane. Glass transition temperature, measured by differential scanning calorimetry at 10 °C/min on the second heat, falls near 45–50 °C for dried polymer. The material has no melting endotherm because of its amorphous character. Storage below −15 °C under dry nitrogen in sealed foil-laminate pouches is required; repeated warming to room temperature should be limited to avoid condensation.

B6010-3 typical property envelope

Property	Method / condition	Typical value or release window
DL-lactide:glycolide ratio	¹H NMR, CDCl₃	50:50
End group	Acid titration	Carboxylic acid
Inherent viscosity	ASTM D2857 / ISO 1628-1, CHCl₃, 30 °C, 0.1 g/dL	0.25–0.35 dL/g
Glass transition	DSC, 10 °C/min, second heat	45–50 °C
Residual monomers	GC-FID	Lot CoA
Residual tin	ICP-MS	Lot CoA

Melt processing of B6010-3 is sensitive to water and residence time. The polymer should be dried under vacuum at 25–35 °C for 16–24 h to a residual moisture content below 0.1 wt% before extrusion or injection molding. Drying at higher temperatures can initiate chain hydrolysis and reduce molecular weight; the acid-terminated end group is more hygroscopic than an ester-capped equivalent and accelerates moisture uptake at relative humidity above 50 %. Production-scale extrusion of acid-terminated 50:50 DL-PLG has shown moisture-induced viscosity loss at the die if hopper purge is inadequate. Co-rotating twin-screw compounders with L/D 25:1 to 40:1 and segmented screw elements are used to limit residence time. Feeding under nitrogen with a dew point below −40 °C reduces adsorption. Barrel temperature set points are often ramped from 120 °C at the feed throat to 150 °C at the die, but the melt may reach higher local temperature from shear heating; screw speeds above 150 rpm require torque monitoring. A melt pump is preferred to reduce surging. Strand pelletizing with chilled air or water quench must be followed by immediate drying because surface condensation accelerates hydrolysis. In injection molding, low clamp force and slow injection rates are used; mold temperatures are held below 30 °C to permit ejection without distortion. Published data for this specific configuration is limited beyond general class behavior; machine trials are required to map residence-time and temperature.

When solvent-based microsphere fabrication is required

Solvent-based routes are often selected over melt processing when low processing temperatures and high encapsulation efficiency are required. B6010-3 dissolves readily in dichloromethane at polymer loadings between 50 mg/mL and 200 mg/mL; the organic phase is emulsified into an aqueous continuous phase containing 0.5–1.0 wt% poly(vinyl alcohol) having a hydrolysis degree of 87–89 % and a weight-average molecular weight near 13,000–23,000 g/mol. A rotor-stator homogenizer operated at 3,000–10,000 rpm or a high-shear mixer at 10,000–20,000 rpm disperses the polymer phase; particle size is monitored by laser diffraction under ISO 13320 and reported as D10, D50, and D90. Solvent removal is performed by evaporation at 30–40 °C under reduced pressure, followed by lyophilization at shelf temperatures below −20 °C. Residual dichloromethane in the finished microspheres should meet ICH Q3C limits or be validated to the relevant pharmacopoeial monograph. Because B6010-3 is acid-terminated, addition of water-soluble amines during processing can cause pH-induced hydrolysis; buffered continuous phases above pH 8 should be avoided.

Bulk hydrolysis controls the absorption profile of B6010-3

Degradation of B6010-3 in aqueous media proceeds by random ester hydrolysis throughout the polymer matrix, not by surface erosion. At 37 °C in phosphate-buffered saline at pH 7.4, molecular weight declines before mass loss, and water uptake increases with time. The carboxylic acid chain end reduces initial hydrophobicity and shortens the induction period observed with ester-capped 50:50 DL-PLG of comparable viscosity. As hydrolysis proceeds, lactic acid and glycolic acid accumulate; in specimens thicker than 1 mm, acid diffusion is slower than acid generation, producing an autocatalytic core-degradation effect. In microspheres below 30 µm in diameter, the short diffusion path reduces internal pH drop. Mass loss is typically delayed until the number-average molecular weight falls below roughly 10,000 g/mol and oligomers become water-soluble. The 50:50 comonomer ratio provides the fastest hydrolysis among the common PLG materials; 75:25 and 85:15 grades degrade more slowly because higher lactide content increases hydrophobicity and reduces ester-bond accessibility. In vitro degradation studies are designed according to ASTM F1635 or ISO 13781, with periodic measurement of pH, mass remaining, molecular weight, and mechanical properties. Published data for this specific configuration is limited beyond general class behavior; lot-specific degradation testing is required for final-device design. Differentiation from other products is based on end-group chemistry, stereochemistry, and comonomer ratio. An ester-capped 50:50 DL-PLG with the same viscosity is less hygroscopic and resists initial hydration; it is used when a slower water-uptake induction phase is needed. A 50:50 PLG prepared from L-lactide rather than DL-lactide may retain some crystallinity or form stereocomplex domains; B6010-3 remains amorphous and dissolves without a melt crystallite memory. Homopolymers such as poly(L-lactide) exhibit much longer absorption times and higher tensile modulus; they are not interchangeable with B6010-3 for short- to medium-duration release matrices. The terminal carboxylic acid on B6010-3 also permits carbodiimide-mediated conjugation for surface modification; anhydrous conditions are required because water hydrolyzes the active ester intermediate. However, amine-containing additives and strong bases should be limited because of base-catalyzed ester hydrolysis. The final device manufacturer is responsible for biocompatibility assessment under ISO 10993-1, with specific endpoints such as cytotoxicity under ISO 10993-5, irritation under ISO 10993-10, acute systemic toxicity under ISO 10993-11, and genotoxicity under ISO 10993-3. Residual-solvent compliance is assessed under ICH Q3C, and sterilization validation falls under ISO 11137 or ISO 11135.

Comparative position of B6010-3 among lactide/glycolide products

Product form	End group	Morphology	Relative hydration / degradation
B6010-3 50:50 DL-PLG	Carboxylic acid	Amorphous	Fast hydration; shortened induction
Ester-capped 50:50 DL-PLG	Ester	Amorphous	Slower initial hydration
75:25 DL-PLG	Acid or ester	Amorphous	Slower; increased lactide hydrophobicity
Poly(L-lactide)	Acid or ester	Semicrystalline	Much slower; high modulus

Raw material qualification for B6010-3 typically includes supplier lot traceability, tamper-evident packaging verification, and storage-environment monitoring. The polymer resin is not supplied as a sterilized device component; therefore, endotoxin limits, bioburden, and sterility assurance levels are not established by the resin manufacturer. Acetone, ethyl acetate, and tetrahydrofuran solutions should be prepared fresh because hydrolysis can occur in solvent-water mixtures during extended storage. If the product is stored outside the recommended low-temperature range, the lot may absorb atmospheric moisture; drying alone does not restore already hydrolyzed chains. These operational boundaries are especially relevant during scale-up from laboratory solvent casting to cleanroom microsphere manufacturing, where batch-to-batch particle size and residual solvent depend on evaporator vacuum control, condenser temperature, and lyophilizer shelf uniformity.